受强制性开放获取政策约束的文章 - Yoseph Caraco了解详情
无法在其他位置公开访问的文章：1 篇
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects
C Shaul, S Blotnick, M Muszkat, M Bialer, Y Caraco
Molecular diagnosis & therapy 21, 75-83, 2017
强制性开放获取政策： US National Science Foundation
可在其他位置公开访问的文章：9 篇
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy
H Lochmüller, A Behin, Y Caraco, H Lau, M Mirabella, I Tournev, ...
Neurology 92 (18), e2109-e2117, 2019
强制性开放获取政策： US National Institutes of Health
Aceneuramic acid extended release administration maintains upper limb muscle strength in a 48-week study of subjects with GNE myopathy: results from a phase 2, randomized …
Z Argov, Y Caraco, H Lau, A Pestronk, PB Shieh, A Skrinar, T Koutsoukos, ...
Journal of neuromuscular diseases 3 (1), 49-66, 2016
强制性开放获取政策： US National Institutes of Health
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: a randomized, placebo-controlled phase 2 study
N Giladi, T Gurevich, R Djaldetti, L Adar, R Case, S Leibman-Barak, ...
Parkinsonism & Related Disorders 91, 139-145, 2021
强制性开放获取政策： Michael J Fox Foundation, Parkinson's Foundation, USA
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: findings from the ND0612 clinical development program
PA LeWitt, F Stocchi, D Arkadir, Y Caraco, L Adar, I Perlstein, R Case, ...
Frontiers in Neurology 13, 1036068, 2022
强制性开放获取政策： US National Institutes of Health, Michael J Fox Foundation, Parkinson's …
Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults
M Muszkat, O Bialer, S Blotnick, L Adar, HG Xie, M Ufer, I Cascorbi, ...
Clinical therapeutics 32 (2), 347-356, 2010
强制性开放获取政策： US National Institutes of Health
The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)‐Warfarin
M Wanounou, C Shaul, Z Abu Ghosh, S Alamia, Y Caraco
Clinical Pharmacology & Therapeutics 112 (1), 156-163, 2022
强制性开放获取政策： US National Science Foundation
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin
C Shaul, S Blotnick, L Deutsch, G Rosenberg, Y Caraco
European Journal of Clinical Pharmacology 75, 343-350, 2019
强制性开放获取政策： US National Science Foundation
Comparison of CYP2C9 activity in Ethiopian and non-Ethiopian jews using phenytoin as a probe
Z Abu Ghosh, S Alamia, C Shaul, Y Caraco
Frontiers in Pharmacology 11, 566842, 2020
强制性开放获取政策： US National Science Foundation
出版信息和资助信息由计算机程序自动确定